<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab6">
 <label>Table 71.6</label>
 <caption>
  <p>Frequency of resistance emergence to oseltamivir or zanamivir during treatment</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Drug/study</th>
    <th>Population</th>
    <th>Assay</th>
    <th>Virus type</th>
    <th>No. isolates tested</th>
    <th>No. (%) resistant</th>
    <th>Mutations detected</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="7">
     <italic>Oseltamivir</italic>
    </td>
   </tr>
   <tr>
    <td>Gubareva et al. [
     <xref ref-type="bibr" rid="CR148">148</xref>]
    </td>
    <td>Adults</td>
    <td>NAI, S</td>
    <td>A/H1N1</td>
    <td>54</td>
    <td>2 (4 %)</td>
    <td>2 His274 Tyr</td>
   </tr>
   <tr>
    <td>Roberts [
     <xref ref-type="bibr" rid="CR146">146</xref>]
    </td>
    <td>Adults</td>
    <td>NAI, S</td>
    <td>A/H3N2</td>
    <td>418</td>
    <td>5 (1 %)</td>
    <td>4 Arg292Lys, 1 Glu119Val</td>
   </tr>
   <tr>
    <td rowspan="2">Whitley et al. [
     <xref ref-type="bibr" rid="CR222">223</xref>]
     <sup>a</sup>
    </td>
    <td rowspan="2">Children—outpatient</td>
    <td rowspan="2">NAI, S</td>
    <td rowspan="2">A&amp;B</td>
    <td>150 A</td>
    <td>10 (6.7 %)</td>
    <td rowspan="2">8 Arg292Lys, 1 Glu119Val, 1 His274Tyr</td>
   </tr>
   <tr>
    <td>66 B</td>
    <td>0</td>
   </tr>
   <tr>
    <td>Kiso et al. [
     <xref ref-type="bibr" rid="CR8">8</xref>]
     <sup>a</sup>
    </td>
    <td>Children—outpatient + hospitalized</td>
    <td>Cloning + S</td>
    <td>A/H3N2</td>
    <td>50</td>
    <td>9 (18 %)</td>
    <td>6 Arg292Lys, 2 Glu119Val, 1 Asn294Ser</td>
   </tr>
   <tr>
    <td rowspan="2">Ward et al. [
     <xref ref-type="bibr" rid="CR223">224</xref>]
     <sup>a</sup>
    </td>
    <td>Children—outpatient + hospitalized</td>
    <td>NAI, S</td>
    <td rowspan="2">B</td>
    <td rowspan="2">74</td>
    <td>7 (16 %)</td>
    <td>7 His274Tyr</td>
   </tr>
   <tr>
    <td>Children—outpatient</td>
    <td>NAI, S</td>
    <td>1 (1.4 %)</td>
    <td>Gly402ser</td>
   </tr>
   <tr>
    <td rowspan="2">Whitley et al. [
     <xref ref-type="bibr" rid="CR103">103</xref>]
    </td>
    <td rowspan="2">Children + adults outpatient</td>
    <td rowspan="2">NAI, S</td>
    <td rowspan="2">A&amp;B</td>
    <td>759 A</td>
    <td rowspan="2">19 (2.5%)</td>
    <td rowspan="2">17 His275Tyr, 2 Arg292Lys</td>
   </tr>
   <tr>
    <td>256 B</td>
   </tr>
   <tr>
    <td>Hatekayama et al. [
     <xref ref-type="bibr" rid="CR220">221</xref>]
    </td>
    <td>Children—outpatient</td>
    <td>NAI, S</td>
    <td>B</td>
    <td>77</td>
    <td>0</td>
    <td>1 Gly402Ser</td>
   </tr>
   <tr>
    <td rowspan="2">Stephensen et al. [
     <xref ref-type="bibr" rid="CR224">225</xref>]
    </td>
    <td rowspan="2">Children—outpatient</td>
    <td rowspan="2">NAI, S</td>
    <td rowspan="2">A&amp;B</td>
    <td>43 A</td>
    <td rowspan="2">1 (1.3%)</td>
    <td rowspan="2">3 His275Tyr, 1Arg292Lys</td>
   </tr>
   <tr>
    <td>19 B</td>
   </tr>
   <tr>
    <td rowspan="2">Harvala et al. [
     <xref ref-type="bibr" rid="CR225">227</xref>]
    </td>
    <td rowspan="2">Children—outpatient</td>
    <td rowspan="2">NAI, S</td>
    <td rowspan="2">A</td>
    <td rowspan="2">32 A</td>
    <td>4 (7.4%)</td>
    <td rowspan="2">5 His275Tyr</td>
   </tr>
   <tr>
    <td>0</td>
   </tr>
   <tr>
    <td rowspan="2">Tramontana et al. [
     <xref ref-type="bibr" rid="CR301">226</xref>]
    </td>
    <td>Adults + children hospitalized</td>
    <td>PCR</td>
    <td>A</td>
    <td>30 A</td>
    <td>5 (15.6%)</td>
    <td>4 His275Tyr</td>
   </tr>
   <tr>
    <td>Adults—hospitalized</td>
    <td>NAI, S</td>
    <td/>
    <td/>
    <td>4 (13.3 %)</td>
    <td/>
   </tr>
   <tr>
    <td colspan="7">
     <italic>Zanamivir</italic>
    </td>
   </tr>
   <tr>
    <td>Barnett et al. [
     <xref ref-type="bibr" rid="CR88">88</xref>]
    </td>
    <td>Adults</td>
    <td>NAI, S</td>
    <td>A + B</td>
    <td>41</td>
    <td>0</td>
    <td/>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <sup>a</sup>These pediatric studies used a 2 mg/kg dose of oseltamivir that has been shown to give reduced drug exposure because of more rapid clearance in children under the age of 5 years. Insufficient drug exposure may have contributed to resistance emergence in these studies
  </p>
 </table-wrap-foot>
</table-wrap>
